Showing results (2201-2210 of 2,317) with videos related to
Sort By:
Pageof 232
Hepatology International|November 12, 2022
Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitisFeng Gao, De-Chan Lu, Tian-Lei Zheng, et al.Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|October 14, 2025
[Mechanism of Chaijin Jieyu Anshen Formula in regulating synaptic damage in nucleus accumbens neurons of rats with insomnia complicated with depression through TREM2/C1q axis]Ying-Juan Tang, Jia-Cheng Dai, Song Yang, et al.Medicine|November 13, 2015
Selected Cytokines Serve as Potential Biomarkers for Predicting Liver Inflammation and Fibrosis in Chronic Hepatitis B Patients With Normal to Mildly Elevated AminotransferasesYong-Qiong Deng, Hong Zhao, An-Lin Ma, et al.Research (Washington, D.C.)|October 6, 2025
Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-PaclitaxelQiuxia Yang, Yize Mao, Yulong Han, et al.Frontiers in Chemistry|October 7, 2022
Characterization of light chain c-terminal extension sequence variant in one bispecific antibodyJun Lin, Mengyu Xie, Dan Liu, et al.Science Advances|June 28, 2019
Electric field-induced selective catalysis of single-molecule reactionXiaoyan Huang, Chun Tang, Jieqiong Li, et al.Angewandte Chemie (International Ed. in English)|January 8, 2015
NeuO: a fluorescent chemical probe for live neuron labelingJun Cheng Er, Cheryl Leong, Chai Lean Teoh, et al.Immunity|December 23, 2022
Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinomaRui-Qi Wu, Xiang-Ming Lao, Dong-Ping Chen, et al.Journal of Hepatology|May 31, 2016
Response-guided peginterferon therapy in patients with HBeAg-positive chronic hepatitis B: A randomized controlled studyJian Sun, Hong Ma, Qing Xie, et al.Liver Cancer|January 19, 2026
Pathological Complete Response after Systemic Therapy and Curative Resection in Initially Unresectable Hepatocellular Carcinoma: Feasibility of a Tumor-Free with Drug-Free StrategyQingyang Lin, Wei Peng, Xi Yu, et al.Pageof 232